Stay updated on Botensilimab in Metastatic Pancreatic Cancer Clinical Trial
Sign up to get notified when there's something new on the Botensilimab in Metastatic Pancreatic Cancer Clinical Trial page.

Latest updates to the Botensilimab in Metastatic Pancreatic Cancer Clinical Trial page
- Check2 days agoNo Change Detected
- Check10 days agoNo Change Detected
- Check17 days agoChange DetectedAdded site revision v3.5.0 and removed revision v3.4.3.SummaryDifference0.1%

- Check24 days agoNo Change Detected
- Check31 days agoChange DetectedRevision: v3.4.3 was added and Revision: v3.4.2 was removed from the study history. This is an update to the page’s version history rather than to the trial data or content.SummaryDifference0.1%

- Check52 days agoChange DetectedVersion history shows a new revision v3.4.2 added and revision v3.4.1 removed, reflecting administrative updates to the record rather than changes to trial data. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

- Check60 days agoChange DetectedThe history table shows a new revision entry (v3.4.1) and removal of v3.4.0 as part of administrative versioning updates. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.2%

- Check81 days agoChange DetectedA new revision entry (v3.3.4) was added to the record history, and the previous revision (v3.3.3) was removed. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

- Check103 days agoChange DetectedAdded a new revision entry v3.3.3 to the Study Record Versions history; removed the items HHS Vulnerability Disclosure and Revision: v3.3.2 from the page.SummaryDifference0.2%

Stay in the know with updates to Botensilimab in Metastatic Pancreatic Cancer Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Botensilimab in Metastatic Pancreatic Cancer Clinical Trial page.